date,title,source
Oct-23-18,FDA Grants Orphan Drug Designation to Omeros OMS721 for Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy,Business Wire
Oct-23-18,"New Research: Key Drivers of Growth for Hecla Mining, Atlas Air Worldwide, Encana, Omeros, Lowe's Companies, and Oaktree Specialty Lending  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Nov-05-18,"Omeros Corporation to Announce Third Quarter 2018 Financial Results on November 9, 2018",Business Wire
Nov-08-18,"Omeros (OMER) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-08-18,Omeros: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Omeros Announces Proposed $210 Million Offering of Convertible Senior Notes Due 2023,PR Newswire
Nov-08-18,Omeros Corporation Reports Third Quarter 2018 Financial Results,Business Wire
